Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001193125-26-006291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-07 | 2026-01-05 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $9.21 | -10.4K | 101.5K | -9% | -$95.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | S | D | 10,397 | $9.21 | 101,528 | D | — | — |